162 related articles for article (PubMed ID: 37343527)
1. Prevalence of Hidradenitis Suppurativa in an African Population: Validation of a Screening Questionnaire in Lagos, Nigeria.
Anaba EL; Bouazzi D; Ajayi PV; Aro OO; Boer J; Jemec GBE
Dermatology; 2023; 239(5):832-835. PubMed ID: 37343527
[TBL] [Abstract][Full Text] [Related]
2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
3. The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled Analysis.
Bouazzi D; Andersen RK; Vinding GR; Medianfar CE; Nielsen SM; Saunte DML; Chandran NS; van der Zee HH; Zouboulis CC; Benhadou F; Villumsen B; Alavi A; Ibekwe PU; Hamzavi IH; Ingram JR; Naik HB; Garg A; Boer J; Christensen R; Jemec GBE
Dermatology; 2024; 240(3):369-375. PubMed ID: 38354718
[TBL] [Abstract][Full Text] [Related]
4. Screening for Diabetes Mellitus in Patients with Hidradenitis Suppurativa-A Monocentric Study in Germany.
Abu Rached N; Gambichler T; Ocker L; Dietrich JW; Quast DR; Sieger C; Seifert C; Scheel C; Bechara FG
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047569
[TBL] [Abstract][Full Text] [Related]
5. Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study.
Calao M; Wilson JL; Spelman L; Billot L; Rubel D; Watts AD; Jemec GBE
PLoS One; 2018; 13(7):e0200683. PubMed ID: 30040827
[TBL] [Abstract][Full Text] [Related]
6. Questionnaire-based epidemiological study of hidradenitis suppurativa in Japan revealing characteristics different from those in Western countries.
Hayama K; Fujita H; Hashimoto T; Terui T;
J Dermatol; 2020 Jul; 47(7):743-748. PubMed ID: 32441411
[TBL] [Abstract][Full Text] [Related]
7. Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
Włodarek K; Stefaniak A; Matusiak Ł; Szepietowski JC
Dermatology; 2020; 236(1):8-14. PubMed ID: 31487719
[TBL] [Abstract][Full Text] [Related]
8. A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.
Hessam S; Scholl L; Sand M; Schmitz L; Reitenbach S; Bechara FG
JAMA Dermatol; 2018 Mar; 154(3):330-335. PubMed ID: 29417136
[TBL] [Abstract][Full Text] [Related]
9. Demographic and Clinical Features of Hidradenitis Suppurativa in Turkey.
Yüksel M; Basım P
J Cutan Med Surg; 2020; 24(1):55-59. PubMed ID: 31698918
[TBL] [Abstract][Full Text] [Related]
10. Hidradenitis suppurativa in surgeons' practice: Prevalence and treatment approach according to the Hurley stage in Latvia.
Balcere A; Upeniece I; Snipe K; Jezupovs A
Dermatol Ther; 2021 Jan; 34(1):e14687. PubMed ID: 33331018
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic and clinical features of hidradenitis suppurativa.
Parulkar I; Haleem H; Paek SY
Semin Cutan Med Surg; 2017 Jun; 36(2):42-46. PubMed ID: 28538742
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation.
Rondags A; Arends S; Wink FR; Horváth B; Spoorenberg A
Semin Arthritis Rheum; 2019 Feb; 48(4):611-617. PubMed ID: 29751976
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis.
Jfri A; Nassim D; O'Brien E; Gulliver W; Nikolakis G; Zouboulis CC
JAMA Dermatol; 2021 Aug; 157(8):924-931. PubMed ID: 34037678
[TBL] [Abstract][Full Text] [Related]
14. Pain in Hidradenitis Suppurativa: A Cross-sectional Study of 1,795 Patients.
Krajewski PK; Matusiak Ł; von Stebut E; Schultheis M; Kirschner U; Nikolakis G; Szepietowski JC
Acta Derm Venereol; 2021 Jan; 101(1):adv00364. PubMed ID: 33320274
[TBL] [Abstract][Full Text] [Related]
15. Hidradenitis suppurativa and Down syndrome in a single-centre sample: A cross-sectional study.
Hernández-Rodríguez JC; Osorio-Gómez GF; Ortiz-Álvarez J; Lebrón-Martín JA; Conejo-Mir J; Pereyra-Rodríguez JJ
Australas J Dermatol; 2022 Aug; 63(3):e231-e237. PubMed ID: 35567765
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP).
Delany E; Gormley G; Hughes R; McCarthy S; Kirthi S; Markham T; Tobin AM; Murphy M; Kirby B
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):467-473. PubMed ID: 29125658
[TBL] [Abstract][Full Text] [Related]
17. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study.
Deckers IE; Janse IC; van der Zee HH; Nijsten T; Boer J; Horváth B; Prens EP
J Am Acad Dermatol; 2016 Oct; 75(4):755-759.e1. PubMed ID: 27453539
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of permanent stoma in Crohn's disease associated with hidradenitis suppurativa: a case-control study.
Dumont LM; Landman C; Sokol H; Beaugerie L; Cosnes J; Seksik P; Guégan S;
Aliment Pharmacol Ther; 2020 Jul; 52(2):303-310. PubMed ID: 32525586
[TBL] [Abstract][Full Text] [Related]
19. Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice.
Prens EP; Lugo-Somolinos AM; Paller AS; Kerdel F; Duan Y; Teixeira HD; Longcore M; Kimball AB
Am J Clin Dermatol; 2020 Aug; 21(4):579-590. PubMed ID: 32077014
[TBL] [Abstract][Full Text] [Related]
20. Hidradenitis Suppurativa Associated with Down Syndrome Is Characterized by Early Age at Diagnosis.
Giovanardi G; Chiricozzi A; Bianchi L; De Simone C; Dini V; Franceschini C; Garcovich S; Oranges T; Di Raimondo C; Caposiena Caro DR; Romanelli M; Peris K
Dermatology; 2018; 234(1-2):66-70. PubMed ID: 29689550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
